Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice

BackgroundHyperuricemia not only increases the risk of cardiovascular diseases such as dyslipidemia, hypertension, coronary artery disease, obesity, metabolic syndrome, and type-2 diabetes, but also severely impacts kidney function, potentially leading to acute kidney injury and chronic kidney disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Chin-Yuan Liu, Wen-Yu Liu, Yeu-Ching Shi, She-Ching Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2025.1556527/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850031306215260160
author Chin-Yuan Liu
Wen-Yu Liu
Yeu-Ching Shi
She-Ching Wu
author_facet Chin-Yuan Liu
Wen-Yu Liu
Yeu-Ching Shi
She-Ching Wu
author_sort Chin-Yuan Liu
collection DOAJ
description BackgroundHyperuricemia not only increases the risk of cardiovascular diseases such as dyslipidemia, hypertension, coronary artery disease, obesity, metabolic syndrome, and type-2 diabetes, but also severely impacts kidney function, potentially leading to acute kidney injury and chronic kidney disease.MethodsThis study aims to investigate the health benefits of black chokeberry (Aronia melanocarpa) on hyperuricemic mice induced by oxonic acid.ResultThe experimental results showed that black chokeberry had no significant toxic or negative effects in mice. The measurement of uric acid (UA) indicated that black chokeberry suppressed the UA levels. Additionally, the xanthine oxidase activity in the high-dose group was significantly decreased, along with reductions in serum urea nitrogen and creatinine levels. Black chokeberry effectively increased the glutathione levels in hyperuricemic mice and reduced malondialdehyde levels, as well as significantly inhibiting adenosine deaminase activity.ConclusionIts efficacy is comparable to that of the marketed drug allopurinol, underscoring the potential of black chokeberry as a functional product for uric acid reduction.
format Article
id doaj-art-e776b1260cfd4ffbb83be7be697ea80a
institution DOAJ
issn 2296-861X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj-art-e776b1260cfd4ffbb83be7be697ea80a2025-08-20T02:59:00ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2025-05-011210.3389/fnut.2025.15565271556527Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in miceChin-Yuan Liu0Wen-Yu Liu1Yeu-Ching Shi2She-Ching Wu3Department of Food Sciences, National Chiayi University, Chiayi, TaiwanDepartment of Food Safety/Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Food Sciences, National Chiayi University, Chiayi, TaiwanDepartment of Food Sciences, National Chiayi University, Chiayi, TaiwanBackgroundHyperuricemia not only increases the risk of cardiovascular diseases such as dyslipidemia, hypertension, coronary artery disease, obesity, metabolic syndrome, and type-2 diabetes, but also severely impacts kidney function, potentially leading to acute kidney injury and chronic kidney disease.MethodsThis study aims to investigate the health benefits of black chokeberry (Aronia melanocarpa) on hyperuricemic mice induced by oxonic acid.ResultThe experimental results showed that black chokeberry had no significant toxic or negative effects in mice. The measurement of uric acid (UA) indicated that black chokeberry suppressed the UA levels. Additionally, the xanthine oxidase activity in the high-dose group was significantly decreased, along with reductions in serum urea nitrogen and creatinine levels. Black chokeberry effectively increased the glutathione levels in hyperuricemic mice and reduced malondialdehyde levels, as well as significantly inhibiting adenosine deaminase activity.ConclusionIts efficacy is comparable to that of the marketed drug allopurinol, underscoring the potential of black chokeberry as a functional product for uric acid reduction.https://www.frontiersin.org/articles/10.3389/fnut.2025.1556527/fulladenosine deaminaseblack chokeberryhyperuricemiauric acidxanthine oxidase
spellingShingle Chin-Yuan Liu
Wen-Yu Liu
Yeu-Ching Shi
She-Ching Wu
Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
Frontiers in Nutrition
adenosine deaminase
black chokeberry
hyperuricemia
uric acid
xanthine oxidase
title Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
title_full Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
title_fullStr Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
title_full_unstemmed Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
title_short Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
title_sort unveiling the therapeutic benefits of black chokeberry aronia melanocarpa in alleviating hyperuricemia in mice
topic adenosine deaminase
black chokeberry
hyperuricemia
uric acid
xanthine oxidase
url https://www.frontiersin.org/articles/10.3389/fnut.2025.1556527/full
work_keys_str_mv AT chinyuanliu unveilingthetherapeuticbenefitsofblackchokeberryaroniamelanocarpainalleviatinghyperuricemiainmice
AT wenyuliu unveilingthetherapeuticbenefitsofblackchokeberryaroniamelanocarpainalleviatinghyperuricemiainmice
AT yeuchingshi unveilingthetherapeuticbenefitsofblackchokeberryaroniamelanocarpainalleviatinghyperuricemiainmice
AT shechingwu unveilingthetherapeuticbenefitsofblackchokeberryaroniamelanocarpainalleviatinghyperuricemiainmice